User profiles for Marco Frigeni
 | Marco FrigeniASST Papa Giovanni XXIII Verified email at asst-pg23.it Cited by 1092 |
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
In COVID-19, acute respiratory distress syndrome (ARDS) and thrombotic events are frequent,
life-threatening complications. Autopsies commonly show arterial thrombosis and severe …
life-threatening complications. Autopsies commonly show arterial thrombosis and severe …
Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
BackgroundSevere COVID-19 is characterised by interstitial pneumonia and hyperinflammation,
with elevated levels of pro-inflammatory cytokines, such as IL-6. Effective treatments are …
with elevated levels of pro-inflammatory cytokines, such as IL-6. Effective treatments are …
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Regression of hepatitis C virus (HCV)–associated lymphoma with interferon (IFN)-based
antiviral treatment supports an etiological link between lymphoma and HCV infection. In addition…
antiviral treatment supports an etiological link between lymphoma and HCV infection. In addition…
IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study
Background Severe COVID-19 is characterised by interstitial pneumonia and hyperinflammation,
with elevated levels of pro-inflammatory cytokines, such as IL-6. Effective treatments …
with elevated levels of pro-inflammatory cytokines, such as IL-6. Effective treatments …
[HTML][HTML] Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
Severe coronavirus disease 2019 (COVID-19) is characterized by interstitial pneumonia/acute
respiratory distress syndrome and hyperinflammation, with elevated levels of …
respiratory distress syndrome and hyperinflammation, with elevated levels of …
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study
…, L Orsucci, I Defrancesco, M Frigeni… - Blood, The Journal …, 2019 - ashpublications.org
Marginal zone lymphomas (MZLs) are indolent nonfollicular B-cell lymphomas (INFLs) and
have heterogeneous clinical behavior. Recently, time to progression of disease at 24 months …
have heterogeneous clinical behavior. Recently, time to progression of disease at 24 months …
Direct‐acting antivirals in hepatitis C virus‐associated diffuse large B‐cell lymphomas
Background International guidelines suggest hepatitis C virus (HCV) eradication by direct‐acting
antivirals (DAAs) after first‐line immunochemotherapy (I‐CT) in patients with HCV‐…
antivirals (DAAs) after first‐line immunochemotherapy (I‐CT) in patients with HCV‐…
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
The most convincing evidence to support the causal role of hepatitis C virus (HCV) in
lymphomagenesis was provided by the observation of the regression of indolent lymphoma after …
lymphomagenesis was provided by the observation of the regression of indolent lymphoma after …
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts
…, M Marchetti, M Norata, M Frigeni… - American Journal of …, 2023 - Wiley Online Library
To the Editor: Myelodysplastic syndromes (MDS) are myeloid malignancies predominating
in the elderly, characterized by ineffective hematopoiesis and risk of progression to acute …
in the elderly, characterized by ineffective hematopoiesis and risk of progression to acute …
Independent prognostic impact of tumour‐infiltrating macrophages in early‐stage Hodgkin's lymphoma
…, A Maffi, GA Croci, M Varettoni, M Frigeni… - Hematological …, 2017 - Wiley Online Library
Although patients with early‐stage Hodgkin's lymphoma have a high rate of cure, a portion
of these are resistant to or relapse after standard treatment. Current prognostic criteria based …
of these are resistant to or relapse after standard treatment. Current prognostic criteria based …